Breakthrough for 800 Million Patients? Kidney Disease Drug Shows Powerful New Benefits
Research led by Hiddo Lambers Heerspink reveals that a therapy previously associated with diabetic kidney disease may have…
VERTANICAL Receives First European Marketing Authorization for Exilby® as a First-in-Class Non-Opioid Treatment for Chronic Low Back Pain
GRÄFELFING, Germany, June 9, 2026 /PRNewswire/ — VERTANICAL today announced that Exilby® (VER-01) has received marketing authorization in…
Space race comes for pharma: Why drug development is heading to orbit
The highly anticipated SpaceX mega-IPO is part of a space frenzy that is moving beyond satellite connectivity, launch…
Japan passes bill to raise co-payments for prescription drugs similar to OTC counterparts
Japan on Friday passed legislation to raise co-payments for prescription medicines with ingredients and effects similar to over-the-counter…
The Deadly Venom Behind Ozempic—and Why the Miracle Drug Should Have Never Worked
When scientists first discovered the insulin secretion effects of gut hormone GLP-1 in the 1980s, it seemed like…
Scientists Discover Common Medications May Secretly Alter Your Gut for Years
Researchers found that many commonly prescribed drugs, not just antibiotics, were linked to long-lasting microbial changes that could…
Lilly’s Foundayo and lower-dose Zepbound helped people maintain weight loss after switching from higher doses of injectable incretin therapy in two late-phase trials
In ATTAIN-MAINTAIN, participants who transitioned from a maximum tolerated dose (MTD) of Wegovy (semaglutide) to Foundayo maintained all…
When pills change shapes and colors, confusion is a side effect
At the ripe old age of 73, I take six drugs — four prescription and two over-the-counter pills…
Apotex launches Apo‑Semaglutide Injection™, a generic equivalent of Ozempic®, in Canada
TORONTO, May 14, 2026 /PRNewswire/ – Apotex Inc. (“Apotex” or the “Company”), the largest Canadian‑based global health company,…
Capricor Therapeutics accuses Nippon Shinyaku of slow-walking Duchenne drug
Capricor Therapeutics accused Nippon Shinyaku and its U.S. subsidiary of failing to follow through on marketing plans for…
3 Stocks Poised to Disrupt the Healthcare Market by 2030
The biggest mistake investors make with healthcare stocks is assuming the future will look like the past: incremental…
CVS Health (CVS) earnings Q1 2026
A screen displays the logo and trading information for CVS at the New York Stock Exchange, March 24,…